Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CorMedix (CRMD) Consolidated Net Income (2016 - 2025)

CorMedix has reported Consolidated Net Income over the past 16 years, most recently at $14.0 million for Q4 2025.

  • Quarterly results put Consolidated Net Income at $14.0 million for Q4 2025, down 56.9% from a year ago — trailing twelve months through Dec 2025 was $163.1 million (up 14253.43% YoY), and the annual figure for FY2025 was $163.1 million, up 14253.43%.
  • Consolidated Net Income reached $14.0 million in Q4 2025 per CRMD's latest filing, down from $108.6 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $108.6 million in Q3 2025 and bottomed at -$14.5 million in Q1 2024.
  • Median Consolidated Net Income over the past 5 years was -$7.4 million (2021), compared with a mean of $2.9 million.
  • The largest annual shift saw Consolidated Net Income plummeted 74.94% in 2023 before it skyrocketed 4009.63% in 2025.
  • Over 5 years, Consolidated Net Income stood at -$9.7 million in 2021, then increased by 15.08% to -$8.2 million in 2022, then tumbled by 74.94% to -$14.4 million in 2023, then surged by 326.52% to $32.5 million in 2024, then plummeted by 56.9% to $14.0 million in 2025.
  • Business Quant data shows Consolidated Net Income for CRMD at $14.0 million in Q4 2025, $108.6 million in Q3 2025, and $19.8 million in Q2 2025.